Retailers sue Allergan over dry-eye drug

Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Shares of Allergan PLC rose 1% in premarket trading Monday, after the drug maker reported a fourth-quarter adjusted profit and revenue.....»»

The hundreds of people JPMorgan will fire is a very modest number. But at some point, bank branches will look like chain drug stores and large retailers, where transactions do not require humans......»»

Novartis AG, Merc.....»»

The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain FDA approval, but the new drug will compete with other recently released treatments for........»»

Shares of Allergan gained 0.5% after the Food and Drug Administration approved Ubrelvy, its migraine treatment. In two late-stage clinical trials, more patients who were taking the experimental therapy reported the pain ending within t.....»»

Wilfredo Lee/AP Walgreens, CVS, and Rite Aid announced they are pulling the heartburn medication Zantac and other generic versions from their shelves, citing reports .....»»

Major drug wholesalers and retailers facing a massive lawsuit for allegedly fostering the nation's opioid crisis asked the judge hearing the case to recuse himself on Saturday......»»

The announcements on Thursday follow similar moves by Walmart and Kroger (NEW YORK) — Drug chains CVS and Walgreens as well a.....»»

Some two dozen opioid manufacturers, drug distributors and retailers are now being sued by states, counties, cities a.....»»

My investment management firm has a large position in the health care sector, and with AbbVie’s bid for Allergan earlier this week, it’s timely to review why we bought into this sectorRelated Stocks: ABBV, AGN, MCK, WBA,.....»»

AbbVie's acquisition of the Botox maker isn't a great reflection on the state of big pharma innovation. Good afternoon, readers. Let’s parse the.....»»

AbbVie (ABBV) is on the hunt for their next big revenue driver as their patent for the world???s top-selling drug, Humira, is nearing its end. AbbVie just made a $63 billion deal to acquire Dublin-based Allergan (AGN) in an a.....»»

AbbVie Inc. said it's buying Dublin, Ireland-based drug firm Allergan in a $63 billion deal. AbbVie (NYSE: ABBV), based in North Chicago, Illinois, said it's paying 0.8660 of its shares and $120.30 in cash for each Allergan (NYSE: AGN) share, for .....»»

AbbVie, maker of the world's best-selling drug, is buying Botox maker Allergan in a blockbuster deal. Here's what that says about the state of biopharma. A.....»»

AbbVie, which produces the blockbuster drug Humira, is buying the maker of Botox, Allergan, for about $63 billion. As Fred Katayama reports, AbbVie was under pressure to diversify its lineup of drugs......»»

Shares of drug makers were getting a nice boost in premarket trading Tuesday, after AbbVie Inc.'s deal to buy Aller.....»»

Just months after Bristol-Myers Squibb and Celgene announced one of the biggest drug industry tie-ups in recent memory.....»»

The U.S. Food and Drug Administration has approved Allergan Plc's CoolTone device for use in strengthening, toning and firming the abdominal area, buttoc.....»»